Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:2227-2236
Published online before print October 7, 2004, doi: 10.1161/01.ATV.0000147534.69062.dc
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
24/12/2227    most recent
01.ATV.0000147534.69062.dcv1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stoll, L. L.
Right arrow Articles by Weintraub, N. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stoll, L. L.
Right arrow Articles by Weintraub, N. L.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Related Collections
Right arrow Pathophysiology
Right arrow Mechanism of atherosclerosis/growth factors
Right arrow Other Vascular biology
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:2227.)
© 2004 American Heart Association, Inc.


Brief Reviews

Potential Role of Endotoxin as a Proinflammatory Mediator of Atherosclerosis

Lynn L. Stoll; Gerene M. Denning; Neal L. Weintraub

From the Department of Internal Medicine, Divisions of Cardiovascular Diseases (L.L.S., N.L.W.) and Infectious Diseases (G.M.D.), University of Iowa and The VA Medical Center, Iowa City, Iowa.

Correspondence to Dr Lynn L. Stoll, Department of Internal Medicine, Division of Cardiovascular Diseases, E 317C GH, University of Iowa, Iowa City, IA 52242. E-mail stolll{at}mail.medicine.uiowa.edu

Atherosclerosis is increasingly recognized as a chronic inflammatory disease. Although a variety of inflammatory markers (ie, C-reactive protein) have been associated with atherosclerosis and its consequences, it is important to identify principal mediators of the inflammatory responses. One potentially important source of vascular inflammation in atherosclerosis is bacterial endotoxin. Mutations in Toll-like receptor 4 (TLR-4), an integral component of the endotoxin signaling complex, are fairly common in the Caucasian population and have recently been associated with reduced incidence of atherosclerosis and other cardiovascular diseases in some studies. Moreover, epidemiological studies suggest that endotoxemia at levels as low as 50 pg/mL constitutes a strong risk factor for the development of atherosclerosis. Endotoxin concentrations in this range may be produced by a variety of common subclinical Gram-negative infections. In this article, we outline the main elements of the endotoxin signaling receptor complex that initiates proinflammatory signaling (lipopolysaccharide binding protein [LBP], CD14, TLR-4, and MD-2) and discuss how changes in expression of these molecules may affect proatherogenic responses in the vessel wall. We also describe some of the proinflammatory effects of endotoxin that may be relevant to atherosclerosis, and discuss how serum lipoproteins, especially high-density lipoprotein, may modulate endotoxin-induced inflammatory responses. Further, we discuss recent findings suggesting that the lipid-lowering statins may have an additional protective role in blocking at least some of these proinflammatory signaling pathways. Finally, we discuss species diversity with regard to endotoxin signaling that should be considered when extrapolating experimental data from animal models to humans.

Bacterial endotoxin is a potential source of vascular inflammation and may be an important risk factor for atherosclerosis. Here, we discuss the endotoxin signaling pathway, vascular proinflammatory effects of endotoxin and their relevance to atherogenesis, interactions between endotoxin and serum lipoproteins, and possible immunomodulatory effects of statins.


Key Words: inflammation • vascular smooth muscle cells • endothelial cells • lipopolysaccharide • species specificity




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. Li and B. Frei
Prolonged Exposure to LPS Increases Iron, Heme, and p22phox Levels and NADPH Oxidase Activity in Human Aortic Endothelial Cells: Inhibition by Desferrioxamine
Arterioscler. Thromb. Vasc. Biol., May 1, 2009; 29(5): 732 - 738.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Ni, Y. Wang, M. Zhang, P. F. Zhang, S. F. Ding, C. X. Liu, X. L. Liu, Y. X. Zhao, and Y. Zhang
Atherosclerotic plaque disruption induced by stress and lipopolysaccharide in apolipoprotein E knockout mice
Am J Physiol Heart Circ Physiol, May 1, 2009; 296(5): H1598 - H1606.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
H. Ghanim, P. Mohanty, R. Deopurkar, C. Ling Sia, K. Korzeniewski, S. Abuaysheh, A. Chaudhuri, and P. Dandona
Acute Modulation of Toll-Like Receptors by Insulin
Diabetes Care, September 1, 2008; 31(9): 1827 - 1831.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
K.A. E. Kallio, K. Buhlin, M. Jauhiainen, R. Keva, A. M. Tuomainen, B. Klinge, A. Gustafsson, and P. J. Pussinen
Lipopolysaccharide associates with pro-atherogenic lipoproteins in periodontitis patients
Innate Immunity, August 1, 2008; 14(4): 247 - 253.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Malarstig, S. Sigurdsson, P. Eriksson, G. Paulsson-Berne, U. Hedin, L. Wallentin, A. Siegbahn, A. Hamsten, and A.-C. Syvanen
Variants of the Interferon Regulatory Factor 5 Gene Regulate Expression of IRF5 mRNA in Atherosclerotic Tissue But Are Not Associated With Myocardial Infarction
Arterioscler. Thromb. Vasc. Biol., May 1, 2008; 28(5): 975 - 982.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
C.-C. Szeto, B. C.-H. Kwan, K.-M. Chow, K.-B. Lai, K.-Y. Chung, C.-B. Leung, and P. K.-T. Li
Endotoxemia is Related to Systemic Inflammation and Atherosclerosis in Peritoneal Dialysis Patients
Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(2): 431 - 436.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
C. Erridge, T. Attina, C. M Spickett, and D. J Webb
A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation
Am. J. Clinical Nutrition, November 1, 2007; 86(5): 1286 - 1292.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Rajesh, P. Mukhopadhyay, S. Batkai, G. Hasko, L. Liaudet, J. W. Huffman, A. Csiszar, Z. Ungvari, K. Mackie, S. Chatterjee, et al.
CB2-receptor stimulation attenuates TNF-{alpha}-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion
Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2210 - H2218.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
N. Sandbo, S. Taurin, D. M. Yau, S. Kregel, R. Mitchell, and N. O. Dulin
Downregulation of smooth muscle {alpha}-actin expression by bacterial lipopolysaccharide
Cardiovasc Res, May 1, 2007; 74(2): 262 - 269.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Frolov and D. Y. Hui
The Modern Art of Atherosclerosis: A Picture of Colorful Plants, Cholesterol, and Inflammation
Arterioscler. Thromb. Vasc. Biol., March 1, 2007; 27(3): 450 - 452.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. Suzuki, E. Bayna, H. L. Li, E. D. Molle, and W. Y.W. Lew
Lipopolysaccharide Activates Calcineurin in Ventricular Myocytes
J. Am. Coll. Cardiol., January 30, 2007; 49(4): 491 - 499.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. Jayachandran, G. J. Brunn, K. Karnicki, R. S. Miller, W. G. Owen, and V. M. Miller
In vivo effects of lipopolysaccharide and TLR4 on platelet production and activity: implications for thrombotic risk
J Appl Physiol, January 1, 2007; 102(1): 429 - 433.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. Erridge, C. M. Spickett, and D. J. Webb
Non-enterobacterial endotoxins stimulate human coronary artery but not venous endothelial cell activation via Toll-like receptor 2
Cardiovasc Res, January 1, 2007; 73(1): 181 - 189.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. Li and B. Frei
Iron Chelation Inhibits NF-{kappa}B-Mediated Adhesion Molecule Expression by Inhibiting p22phox Protein Expression and NADPH Oxidase Activity
Arterioscler. Thromb. Vasc. Biol., December 1, 2006; 26(12): 2638 - 2643.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
A. Kontush and M. J. Chapman
Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis
Pharmacol. Rev., September 1, 2006; 58(3): 342 - 374.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
M. K. Mohammad, M. Morran, B. Slotterbeck, D. W. Leaman, Y. Sun, H. v. Grafenstein, S.-C. Hong, and M. F. McInerney
Dysregulated Toll-like receptor expression and signaling in bone marrow-derived macrophages at the onset of diabetes in the non-obese diabetic mouse
Int. Immunol., July 1, 2006; 18(7): 1101 - 1113.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. M. Doherty, P. K. Shah, M. Arditi, L. L. Stoll, G. M. Denning, and N. L. Weintraub
Lipopolysaccharide, Toll-Like Receptors, and the Immune Contribution to Atherosclerosis
Arterioscler. Thromb. Vasc. Biol., May 1, 2005; 25(5): e38 - e39.
[Full Text] [PDF]


Home page
CirculationHome page
A. Warnholtz, S. Genth-Zotz, and T. Munzel
Should Treatment of Sepsis Include Statins?
Circulation, April 12, 2005; 111(14): 1735 - 1737.
[Full Text] [PDF]